Onemednet CORP 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NASDAQ
ONMD
Onemednet CORPOneMedNet Corporation reported a net loss of $0.7 million for Q3 2025, narrowing from the prior year, driven by a strategic pivot to web imaging revenue and significant debt restructurings, while facing substantial doubt about its ability to continue as a going concern.
NASDAQ
ONMD
Onemednet CORPOneMedNet Corporation reported net income for Q2 2025 driven by debt restructuring gains, despite a significant overall revenue decrease and ongoing going concern doubts.
NASDAQ
ONMD
Onemednet CORPOneMedNet Corporation's Q1 2025 revenue decreased by 45% year-over-year as the company transitions away from its BEAM platform and focuses on iRWD sales.
NASDAQ
ONMD
Onemednet CORPOneMedNet Corporation's Q3 2024 results reveal a net loss and declining revenue, alongside strategic shifts and financial restructuring efforts.
NASDAQ
ONMD
Onemednet CORPOneMedNet Corporation's Q2 2024 results show a revenue increase driven by web imaging, offset by a decrease in subscription revenue, alongside significant changes in financial structure and management.
NASDAQ
ONMD
Onemednet CORPOneMedNet Corporation's first quarter 2024 results show a 24% increase in revenue compared to the same period last year, driven by growth in both subscription and web imaging services.